VBCG
APEN

Valley Brook Capital Group’s Apollo Endosurgery, Inc. APEN Stock Holding History

Valley Brook Capital Group’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2
Closed – – 461
2021
Q1 		$0 Hold
2
– – ﹤0.01% 491
2020
Q4 		$0 Buy
+2
New +$5 ﹤0.01% 409

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Valley Brook Capital Group's APEN Position: Q2 2021 in Review

Valley Brook Capital Group sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2021, closing a stake of 2 shares.

Valley Brook Capital Group first reported a position in APEN in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q1 2021. 46 funds tracked by Wall St. Rank hold APEN as of Q2 2021.

  • Valley Brook Capital Group reported no remaining Apollo Endosurgery, Inc. position as of Q2 2021 after selling out during the quarter.
  • Valley Brook Capital Group sold 2 Apollo Endosurgery, Inc. shares in Q2 2021.
  • Valley Brook Capital Group first reported a position in Apollo Endosurgery, Inc. in Q4 2020 and held it in 2 quarters.
  • Valley Brook Capital Group's Apollo Endosurgery, Inc. position peaked at $0 in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2021.

Based on Valley Brook Capital Group's 13F filing for Q2 2021, filed 22 Jul 2021.